|
|
|
|
| LEADER |
00966nam a2200265 i 4500 |
| 001 |
NSK01000958359 |
| 003 |
HR-ZaNSK |
| 005 |
20170413131555.0 |
| 007 |
ta |
| 008 |
170314s2010 au i000 0 eng |
| 020 |
|
|
|a 9789201016102
|
| 035 |
|
|
|a (HR-ZaNSK)000958359
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 080 |
1 |
|
|a 616-006-08
|2 MRF 2011.
|
| 080 |
1 |
|
|a 621.039:61
|2 MRF 2011.
|
| 110 |
2 |
|
|a International Atomic Energy Agency
|
| 245 |
1 |
0 |
|a Appropriate use of FDG-PET for the management of cancer patients /
|c International Atomic Energy Agency.
|
| 260 |
|
|
|a Vienna :
|b International Atomic Energy Agency,
|c 2010.
|
| 300 |
|
|
|a 75 str. ;
|c 25 cm.
|
| 490 |
0 |
|
|a IAEA human health series,
|x 2075-3772 ;
|v no. 9
|
| 504 |
|
|
|a Bibliografija uz svako poglavlje.
|
| 650 |
|
7 |
|a Karcinom
|x Terapija
|2 nskps
|
| 650 |
|
7 |
|a Pozitronska emisijska tomografija
|2 nskps
|
| 760 |
1 |
8 |
|t IAEA human health series
|x 2075-3772
|g no. 9
|w nsk.(HR-ZaNSK)000878642
|
| 998 |
|
|
|m eemk1703
|c mzoo170413
|
